Abstract
Background
To study maternal–fetal outcomes in patients of GDM diagnosed by International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria but subsequently using a twenty-four-hour seven-value sugar profile to evaluate patients before instituting management.
Methods
This prospective observational study was conducted at a tertiary hospital in New Delhi, India, over a period of one year. During this period, women diagnosed as GDM between 24 and 28 weeks of gestation using IADPSG criteria underwent seven-value sugar profile in twenty-four hours before initiating any therapy. Those with normal profile were kept on observation only, whereas others were managed by Medical Nutrition Therapy (MNT) with or without pharmacotherapy as required to maintain euglycemia. Maternal and fetal outcomes were documented and analysed to detect differences between the groups.
Results
Out of 2279 pregnant women, 201 (8.8%) were diagnosed as GDM. The twenty-four-hour seven-value sugar profile was normal in 78 (38.8%) patients, who were managed only by close observation. Treatment was given to other patients; 93 (46.2%) patients were managed with MNT only, whereas pharmacotherapy by way of metformin was added to 22 (10.9%) patients and 8 (3.9%) patients required insulin. Differences in maternal–fetal outcomes between the treated and untreated groups were not found to be statistically significant.
Conclusions
The policy of evaluating patients with twenty-four-hour seven-value sugar profile after an abnormal Oral Glucose Tolerance Test eliminated over one-third women from receiving treatment and interventions for GDM without compromising maternal–fetal outcomes.
Similar content being viewed by others
References
Farrar D, Simmonds M, Bryant M, et al. Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ. 2016; 354, article i4694.
Buckley BS, Harreiter J, Damm P, et al. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A Rev Diabet Med. 2012;29(7):844–54.
Strawa-Zakoscielna K, Lenart-Lipinska M, Szafraniec A, et al. A new diagnostic perspective—hyperglycemia in pregnancy—as of the year, 2014. Curr Issues Pharm Med Sci. 2014;27(4):246–9.
Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.
Guariguata L, Linnenkamp U, Beagley J, et al. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103(2):176–85.
Tripathi R, Verma D, Gupta VK, et al. Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India] as a diagnostic test for gestational diabetes mellitus. Indian J Med Res. 2017;145(2):209–14.
American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004;27(suppl 1):s88–90.
Costa E, Kirckpartick C, Gerday C, et al. Change in prevalence of gestational diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French speaking University Hospital. A retrospective cohort study. BMC Pregnancy Childbirth. 2019. https://doi.org/10.1186/s12884-019-2406-4.
Li KT, Naik S, Alexander M, Mathad JS. Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis. Acta Diabetol. 2018 Jun; 55(6):613–625. doi: https://doi.org/10.1007/s00592-018-1131-1. Epub 2018 Mar 26. PMID: 29582160; PMCID: PMC5999405.
Bhavadharini B, Mahalakshmi MM, Anjana RM, et al. Prevalence of gestational Diabetes Mellitus in urban and rural Tamil Nadu using IADPSG and WHO 1999 criteria (WINGS 6). Clin Diabetes Endocrinol. 2016;2:8. https://doi.org/10.1186/s40842-016-0028-6.
Celine TM, Antony J. Pattern of birth weight of newborn babies at a tertiary care level. Int J Prev Med. 2012;3(5):375–6.
Hou R-L, Wen Y, Xiag Yang C, et al. Cord blood C-peptide, insulin, HbA1c, and lipids levels in small and large-for-gestational-age newborns. Med Sci Monit. 2014;20:2097–105.
Lanktree MB, Joy TR, Hegele RA. The Metabolic Syndrome, Genomic and Personalized Medicine (SecondEdition): Academic Press; 2013. p.1006–16.
Mohan V, Mahalakshmi MM, Bhavadharini B, et al. Comparison of screening for gestational diabetes mellitus by oral glucose tolerance tests done in the non-fasting (random) and fasting states. Acta Diabetol. 2014;51:1007–13.
Libman IM, Barinas-Mitchell E, Bartucci A, et al. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab. 2008;93(11):4231–7.
Yadav R, Bhartiya JP, Verma SK, Nandkeoliar MK. External quality assessment scheme (EQAS): our experiences as a participating laboratory . IJRRMS ,Vol-3, no.4,October 2013.
Hill P, Uldall A, Wilding P. Fundamentals for External Quality Assessment (EQA) Guidelines for Improving Analytical Quality by Establishing and Managing EQA schemes. Examples from basic chemistry using limited resources. Committee on Analytical Quality (CAQ) of the Education and Management Division of IFCC 1999:1–45. https://www.ifcc.org/media/478098/fundamentals-for-external-quality-assessment-eqa.pdf
Revision of Allowable Limits of Performance.RCPA Quality Assurance Programs Pty Limited, 2010.
Regnault N, Botton J, Heude B, et al. Higher cord C-peptide concentrations are associated with slower growth rate in the 1st year of life in girls but not in boys. Diabetes. 2011;60:2152–9.
Lindsay KL, Brennan L, Rath A et al. Gestational weight gain in obese pregnancy: Impact on maternal and foetal metabolic parameters and birth weight. J Obstet Gynaecol. 2018;38(1):60–5.
Acknowledgments
The help of Dr. Varun Kashyap, Assistant Professor, Biostatistics, HIMSR, New Delhi in statistical analysis is gratefully acknowledged.
Funding
This study did not receive funds from any source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interests to declare.
Ethical Approval
The study has been approved by the Institutional Ethical Committee.
Informed Consent
Informed consent was obtained from the individuals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Farhat Mazhari is a Senior Resident, Department of Obstetrics and Gynaecology, Hamdard Institute of Medical Sciences and Research‚ Jamia Hamdard University, Hamdard Nagar, New Delhi – 110062, Delhi, India.
Rights and permissions
About this article
Cite this article
Tripathi, R., Gupta, N., Mazhari, F. et al. A Prospective Study to Determine if Management of Cases of Gestational Diabetes Mellitus (GDM) can be Modified. J Obstet Gynecol India 72, 147–153 (2022). https://doi.org/10.1007/s13224-021-01507-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-021-01507-9